Loading...

Intellectia LogoIntellectia
AI Trading Bot
Features
Markets
News
Resources
Pricing
Get Started
  1. Home
  2. Stock
  3. TLRY
TLRY logo

TLRY Should I Buy

-
$
0.000
0.000(0.000%)
At close
0.000(0.000%)Aft-market
ET
$
0.000
0.000(0.000%)
At close
0.000(0.000%)Aft-market
ET
OverviewStock Price PredictionTechnicalValuationFinancialsEarningsShould I BuyNews & Events
an image of Intellectia Logoan image of Intellectia

Most Trusted AI Platform for Winning Trades

TwitterYoutubeQuoraDiscordLinkedinTelegram

Copyright © 2026 Intellectia.AI. All Rights Reserved.

Company

  • Home
  • Contact
  • About Us
  • Press
  • Privacy
  • Terms of Service
  • Service Terms of Use

Resources

  • Blog
  • Tutorial
  • Help Center
  • Affiliate Program

Markets

  • Market Analysis
  • Crypto
  • Featured Screeners
  • AI Earnings Calendar
  • Market Movers
  • Stock Monitor
  • Economic Calendar
  • All US Stocks
  • All Cryptos

Tools

  • Dividend Calculator
  • Dividend Yield Calculator
  • Options Profit Calculator

Features

  • QuantAI Alpha Pick
  • SwingMax Portfolio
  • Swing Trading
  • AI Stock Picker
  • Whales Auto Tracker
  • Daytrading Center
  • Patterns Detection
  • AI Screener
  • Financial AI Agent
  • Backtesting Playground
  • AI Earnings Prediction
  • Stock Monitor
  • Technical Analysis

News

  • Overview
  • Top News
  • Daily Market Brief
  • Earnings Analysis
  • Newswire
  • Stock News
  • Crypto News
  • Institution News
  • Congress News
  • Monitor News

Compare

  • TradingView
  • SeekingAlpha
Intellectia

Should You Buy Tilray Brands Inc (TLRY) Today? Analysis, Price Targets, and 2026 Outlook.

Conclusion
Buy
Latest Price
5.560
1 Day change
-1.77%
52 Week Range
23.200
Analysis Updated At
2026/04/24
Should I buy Analysis is updated weekly. For real time "Should I Buy" analysis, please sign up to get free answers.
Sign Up

Tilray Brands Inc (TLRY) is a good buy for a beginner investor with a long-term strategy and $50,000-$100,000 available for investment. The stock benefits from positive regulatory developments, improving financial metrics like gross margin, and favorable options sentiment. Despite some negative financial trends, the long-term growth potential in the cannabis industry and recent regulatory changes make this a compelling investment opportunity.

Technical Analysis

The MACD is positive and contracting, indicating a potential bullish trend. RSI is neutral at 48.875, and moving averages are converging, suggesting no strong directional trend. Key support is at 6.417, and resistance is at 7.555, with the stock trading near its support level, offering a potential entry point.

Options Data

Bullish
Open Interest Put-Call Ratio
Bullish
Option Volume Put-Call Ratio

Options data shows bullish sentiment with a low Put-Call ratio for both open interest and volume, indicating a higher demand for calls over puts.

Technical Summary

StrongSellSellNeutralBuyStrongBuydotted line Image
Sell
10
Buy
4

Positive Catalysts

  • U.S. government reclassification of state-licensed medical marijuana to Schedule III, reducing regulatory hurdles and offering tax relief.

  • Improved gross margin by 55.35% YoY in Q3

  • Analysts upgrading the stock and citing potential regulatory changes as a growth driver.

Neutral/Negative Catalysts

  • Decline in net income (-96.63% YoY) and EPS (-97.24% YoY) in Q3

  • Uncertainty over hemp restrictions and higher aluminum costs impacting the beverage business.

Financial Performance

Revenue increased by 11.28% YoY to $206.73 million in Q3 2026. Gross margin improved significantly to 24.11%, up 55.35% YoY. However, net income dropped to -$26.57 million, and EPS declined to -$0.24, reflecting challenges in profitability.

Growth

Profitability

Efficiency

Analyst Ratings and Price Target Trends

Analysts are mixed but leaning positive. Roth Capital upgraded the stock to Buy with a $10 price target, citing steady Canadian business and improving international operations. However, Canaccord and Alliance Global lowered their price targets, citing challenges in the beverage segment and regulatory uncertainty.

Wall Street analysts forecast TLRY stock price to rise
4 Analyst Rating
Wall Street analysts forecast TLRY stock price to rise
1 Buy
3 Hold
0 Sell
Hold
Current: 5.660
sliders
Low
8.5
Averages
9.57
High
10
Current: 5.660
sliders
Low
8.5
Averages
9.57
High
10
Canaccord
Hold
downgrade
$13
AI Analysis
2026-04-02
Reason
Canaccord
Price Target
$13
AI Analysis
2026-04-02
downgrade
Hold
Reason
Canaccord lowered the firm's price target on Tilray to C$9.50 from C$13 and keeps a Hold rating on the shares.
Roth Capital
Bill Kirk
Neutral
to
Buy
upgrade
$10
2026-04-01
Reason
Roth Capital
Bill Kirk
Price Target
$10
2026-04-01
upgrade
Neutral
to
Buy
Reason
Roth Capital analyst Bill Kirk upgraded Tilray to Buy from Neutral with an unchanged $10 price target. The firm is citing the company's core Canadian business holding steady, inflection in Tilray's international operations and improving beverage category, the analyst tells investors in a research note. Tilray shares are back at July 2025 levels, but the fundamental outlook has improved and the potential for regulatory change is greater, the firm added.
Unlock Full Analyst Thesis, Get the complete breakdown of rating reason for TLRY
Unlock Now

People Also Watch